Related Experiment Video
Updated: Apr 30, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Simvastatin modulates cellular components in influenza A virus-infected cells
Parvaneh Mehrbod1, Mohd Hair-Bejo1, Tengku Azmi Tengku Ibrahim1
1Institute of Bioscience, University Putra Malaysia, Serdang, Selangor 43400, Malaysia.
Simvastatin effectively combats Influenza A virus by reducing viral load and pro-inflammatory cytokines. It inhibits viral replication by modulating GTPase and LC3 pathways, offering a potential new anti-influenza strategy.
Area of Science:
- Virology
- Pharmacology
- Cell Biology
Background:
- Influenza A virus poses a significant global health risk due to continuous antigenic drift and limited vaccine efficacy.
- Statins, known for their pleiotropic effects, are emerging as potential anti-influenza agents due to their anti-inflammatory properties.
Purpose of the Study:
- To investigate the antiviral effects of simvastatin against Influenza A virus in infected cells.
- To elucidate the molecular mechanisms underlying simvastatin's anti-influenza activity.
Main Methods:
- Cell viability was assessed using MTT assay.
- Viral load was quantified by qPCR and hemagglutination assay.
- Pro-inflammatory cytokine expression (TNF-α, IL-6, IFN-γ) was measured via ELISA.
- Actin polymerization, endocytosis, autophagy, GTPase prenylation, and LC3 lipidation were analyzed using rhodamine staining and western blotting.
Main Results:
- Simvastatin treatment maintained cell viability and significantly reduced Influenza A viral load.
- Simvastatin decreased the expression of key pro-inflammatory cytokines by approximately 2-fold.
- Inhibition of GTPase (RhoA, Rabs) and LC3 pathways by simvastatin was shown to impede viral replication.
Conclusions:
- Simvastatin demonstrates significant anti-influenza A activity.
- Modulation of RhoA, Rabs, and LC3 pathways represents a key mechanism for simvastatin's antiviral efficacy.
- Simvastatin holds promise as a therapeutic agent against influenza infections.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Influenza
Leaky Scanning
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

